The BioIndustry Association (BIA) has published new data showing that the UK’s life sciences sector...
Category - Biotechnology
New 36-Month Efficacy and Safety Data for Leqembi (Lecanemab)...
Eisai has announced new 36-month (3-year) efficacy and safety results from its Phase 3 Clarity AD...
BioNTech commits £1 billion to UK research with £129 million...
BioNTech has announced a major expansion of its UK footprint, pledging to invest up to £1 billion...
UK biotech investment remains resilient in H1 2025, says BIA...
The UK’s biotech sector has demonstrated resilience in the first half of 2025, according to the...
uniQure’s AMT-130 Demonstrates Statistically Significant 75 %...
uniQure has announced positive topline results from its pivotal Phase I/II trial of AMT-130 for the...
Pioneering TIL Therapy Delivered for Metastatic Lung Cancer at...
HCA Healthcare UK has delivered its first Tumour-Infiltrating Lymphocyte (TIL) therapy for a...
Lilly launches TuneLab to accelerate AI-driven drug discovery...
Eli Lilly and Company has launched Lilly TuneLab, an artificial intelligence and machine learning...
Sanofi’s Brivekimig Shows Positive Phase 2a Results in...
Sanofi has reported encouraging Phase 2a data for brivekimig, a dual-target Nanobody® molecule...
Novartis to Acquire Tourmaline Bio, Expanding Cardiovascular...
Novartis has announced plans to acquire Tourmaline Bio, strengthening its cardiovascular pipeline...
Libtayo Plus Chemotherapy Delivers Five-Year Survival Benefit in...
Regeneron Pharmaceuticals, Inc. has announced five-year follow-up results from its Phase 3 EMPOWER...